pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Monoclonal Antibody · news · pharmadog
← back to Monoclonal Antibody
News · Monoclonal Antibody
553
stories
Aug 10, 26
Biogen’s targeted ALS treatment is reversing decline in some patients. Can more be helped?
biospace
Aug 6, 26
Third time’s the charm for Replimune as melanoma drug earns FDA greenlight
biospace
Aug 6, 26
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
fda press
Aug 6, 26
Sanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’
biospace
Aug 6, 26
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
globenewswire health
Aug 6, 26
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
globenewswire health
Aug 6, 26
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
fiercebiotech
Aug 5, 26
Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
fiercebiotech
Aug 5, 26
Attovia adds to biotech IPO momentum with $289M offering
biopharma dive
Aug 5, 26
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
biopharma dive
Aug 5, 26
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
fiercebiotech
Aug 5, 26
Gilead looks to upcoming inflammation, cancer catalysts as pressure to diversify mounts
biospace
Aug 5, 26
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
Aug 5, 26
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
Aug 5, 26
5 NextGen winners who went public this year (and which ones are hiring)
biospace
Aug 5, 26
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
Aug 4, 26
Merck plans trial of sac-TMT combo with Keytruda in lung cancer
endpoints
Aug 4, 26
Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss
biospace
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Aug 4, 26
As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca merger
biospace
Aug 4, 26
Amgen drops early-stage obesity drug, upping pressure on MariTide
fiercebiotech
Aug 4, 26
Pathos inks back-to-back cancer contracts with AstraZeneca, China’s Alphamab
biospace
Aug 4, 26
Merck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in SSc-ILD
endpoints
Aug 4, 26
Lisata lays off 72% of staffers, sues Kuva after planned merger falls apart
fiercebiotech
Aug 4, 26
Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials
fiercebiotech
Aug 4, 26
Pathos AI pads pipeline with $2.2B Alphamab deal, AstraZeneca pact
fiercebiotech
Aug 4, 26
Pathos does deals with AstraZeneca, China's Alphamab, seeks up to $300M Series E
endpoints
Aug 3, 26
BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech
biospace
Aug 3, 26
‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal ever
biospace
Aug 3, 26
After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company
fiercebiotech
← prev
page 10 of 19
next →
